Your institution may have access to this item. Find your institution then sign in to continue.
Title
Does a statistically significant survival benefit of erlotinib plus gemcitabine for advanced pancreatic cancer translate into clinical significance and value?
Authors
Miksad, Rebecca A; Schnipper, Lowell; Goldstein, Michael
Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Vol 25, Issue 28, p4506